From the Journals

No link found between fluconazole use and neonatal death risk


 


The stillbirth analysis in the present study included 10,669 fluconazole-exposed pregnancies from Sweden and Norway, though the number exposed to higher doses was small, Dr. Pasterak and co-authors said in their report.


Although more research and deliberation is needed, this new study does add one novel endpoint to the literature: “The outcome of neonatal death has not been reported previously, to our knowledge.”


Their study was supported by the Thrasher Research Fund, the Magnus Bergvall Foundation, and the Karolinska Institutet Research Foundation. Dr. Pasternak and co-authors reported no conflicts of interest.


dermnews@mdedge.com


SOURCE: Pasternak B, et al. JAMA. 2018 Jun 12;319:22.

Pages

Recommended Reading

Babies exposed to SSRIs in utero have decreased LV size
MDedge Family Medicine
CARPREG II fine-tunes assessment of cardiac complication risk in pregnancy
MDedge Family Medicine
FDA warns of birth defect risks from dolutegravir
MDedge Family Medicine
Drug-related deaths continue to rise in United States
MDedge Family Medicine
The FDA’s novel drugs approved in 2017
MDedge Family Medicine
GDM, subsequent diabetes predictive of later renal damage
MDedge Family Medicine
How more midwives may mean healthier mothers
MDedge Family Medicine
Pregnancy may be ideal time to consider switching MS drugs
MDedge Family Medicine
Mifepristone, then misoprostol is best in early pregnancy loss
MDedge Family Medicine
NIH launches HEAL Initiative to combat opioid crisis
MDedge Family Medicine